Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000424116

Medchemexpress LLC Amilo-5MER TFA (5-MP TFA) | 99.6% | 576.66 (free base) | 5 MG
SDP

Catalog No. 5000424116
Encompass_Preferred

Amilo-5MER TFA (5-MP) is an orally active and selective Serum Amyloid A (SAA) inhibitor. It specifically inhibits the release of pro-inflammatory cytokines IL-6 and IL-1β from SAA-activated cells. This compound has shown the ability to reduce chronic inflammation and alleviate symptoms associated with diseases like rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and multiple sclerosis (MS). It is considered promising for research in autoimmune and chronic inflammatory diseases.

  • Orally active and selective Serum Amyloid A (SAA) inhibitor.
  • Specifically inhibits the release of pro-inflammatory cytokines IL-6 and IL-1β from SAA-activated cells.
  • Reduces chronic inflammation.
  • Relieves symptoms of diseases such as rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and multiple sclerosis (MS).
  • Promising for research of autoimmune diseases and chronic inflammatory diseases.

Catalog No. 50-004-24116 Supplier Medchemexpress LLC Supplier No. HYP10935A5MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Amilo-5MER TFA (5-MP) is an orally active and selective Serum Amyloid A (SAA) inhibitor. It specifically inhibits the release of pro-inflammatory cytokines IL-6 and IL-1β from SAA-activated cells. This compound has shown the ability to reduce chronic inflammation and alleviate symptoms associated with diseases like rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and multiple sclerosis (MS). It is considered promising for research in autoimmune and chronic inflammatory diseases.

  • Orally active and selective Serum Amyloid A (SAA) inhibitor.
  • Specifically inhibits the release of pro-inflammatory cytokines IL-6 and IL-1β from SAA-activated cells.
  • Reduces chronic inflammation.
  • Relieves symptoms of diseases such as rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and multiple sclerosis (MS).
  • Promising for research of autoimmune diseases and chronic inflammatory diseases.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.